MENU
KOD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kodiak Sciences (KOD) Ownership - Who owns Kodiak Sciences?

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
1250 Page Mill Road
Phone
+1 650 281-0850
Employees
124
Web
https://www.kodiak.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.29B
P/E Ratio
N/A
Total Cash
169.53M
Projected Growth
N/A
Total Debt
55.99M
Revenue
N/A
Risk (Beta)
2.12
Dividend Yield
N/A
Total Cash/Share
2.71
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
KOD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of retinal disease

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
1250 Page Mill Road
Phone
+1 650 281-0850
Employees
124
Web
https://www.kodiak.com